
Italy Diabetes Drugs and Devices Market Growth, Size, Trends, Share, Revenue and Future Outlook
Italy Diabetes Drugs and Devices Market Size- By Management Devices, By Monitoring Devices- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
Published: Jun-2024 | Report ID: MEDE2432 | Pages: 1 - 106 | Formats*: |
Category : Medical Devices |
- The most innovative insulin delivery device available, the Insulin Pen 2.0TM, was introduced by wearable diabetes technology leader Cequr in June 2022. The pen's compact size allows the user to wear it on their body at all times. In order to help users monitor their blood sugar levels throughout the day, it also has an integrated blood glucose meter.
- New Roche point-of-care blood glucose monitor for hospital staff was introduced in January 2022. It comes with a companion device that resembles a touchscreen smartphone and is used to run the device's apps. In addition to a camera and a touchscreen for recording additional diagnostic data, the portable Cobas pulse has an automatic glucose test strip reader. All patient types, including those in intensive care and infants, can use it.


Report Metric | Details |
Market size available for years | 2020-2033 |
Base year considered | 2023 |
Forecast period | 2024-2033 |
Segments covered | By Management Devices, By Monitoring Devices |
Regions covered | Eastern Region, Western Region, Northern Region, Southern Region |
Companies Covered | Abbott Diabetes Care, Arkray Inc., Ascensia Diabetes Care, Dexcom, Insulet Corporation, Eli Lilly, LifeScan Inc., Medtronic, Novo Nordisk A/S, Roche Diabetes Care, Rossmax International Ltd., Sanofi. |
- Patients with diabetes
- Healthcare professionals (doctors, nurses, pharmacists, etc.)
- Hospitals and clinics
- Pharmaceutical companies
- Medical device manufacturers
- Research institutions and academia
- Government health agencies
- Insurance companies
By Management Devices: |
|
By Monitoring Devices: |
|
- Italy Diabetes Drugs and Devices Market Size (FY’2024-FY’2033)
- Overview of Italy Diabetes Drugs and Devices Market
- Segmentation of Italy Diabetes Drugs and Devices Market By Management Devices (Insulin Pump, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors)
- Segmentation of Italy Diabetes Drugs and Devices Market By Monitoring Devices (Self-Monitoring Devices, Continuous Glucose Monitoring)
- Expansion Analysis of Italy Diabetes Drugs and Devices Market
- Problems and Obstacles in Italy Diabetes Drugs and Devices Market
- Competitive Landscape in the Italy Diabetes Drugs and Devices Market
- Impact of COVID-19 and Demonetization on Italy Diabetes Drugs and Devices Market
- Details on Current Investment in Italy Diabetes Drugs and Devices Market
- Competitive Analysis of Italy Diabetes Drugs and Devices Market
- Prominent Players in the Italy Diabetes Drugs and Devices Market
- SWOT Analysis of Italy Diabetes Drugs and Devices Market
- Italy Diabetes Drugs and Devices Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1.1. Scope of the report1.2. Market segment analysis
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
4.2. COVID-19 Impacts of the Italy Diabetes Drugs and Devices Market
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6.1. Italy Diabetes Drugs and Devices Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Italy Diabetes Drugs and Devices Market
7.1. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Management Devices, 2020-20267.2. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Management Devices, 2027-20337.3. Insulin Pump
7.3.1. Insulin Pump device7.3.2. Insulin Pump Reservoir7.3.3. Infusion Set
7.4. Insulin Syringes7.5. Cartridges in Reusable Pens7.6. Insulin Disposable Pens7.7. Jet Injectors
8.1. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Monitoring Devices, 2020-20268.2. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Monitoring Devices, 2027-20338.3. Self-Monitoring Devices
8.3.1. Glucometer Devices8.3.2. Blood Glucose Test Strips8.3.3. Lancets
8.4. Continuous Glucose Monitoring
8.4.1. Sensors8.4.2. Durables
9.1. Italy Diabetes Drugs and Devices Market Size and Market Share
10.1. Italy Diabetes Drugs and Devices Market Size and Market Share By Region (2020-2026)10.2. Italy Diabetes Drugs and Devices Market Size and Market Share By Region (2027-2033)10.3. Eastern Region10.4. Northern Region10.5. Eastern Region10.6. Western Region
11.1. Abbott Diabetes Care
11.1.1. Company details11.1.2. Financial outlook11.1.3. Product summary11.1.4. Recent developments
11.2. Arkray Inc.
11.2.1. Company details11.2.2. Financial outlook11.2.3. Product summary11.2.4. Recent developments
11.3. Ascensia Diabetes Care
11.3.1. Company details11.3.2. Financial outlook11.3.3. Product summary11.3.4. Recent developments
11.4. Dexcom
11.4.1. Company details11.4.2. Financial outlook11.4.3. Product summary11.4.4. Recent developments
11.5. Insulet Corporation
11.5.1. Company details11.5.2. Financial outlook11.5.3. Product summary11.5.4. Recent developments
11.6. Eli Lilly
11.6.1. Company details11.6.2. Financial outlook11.6.3. Product summary11.6.4. Recent developments
11.7. LifeScan Inc.
11.7.1. Company details11.7.2. Financial outlook11.7.3. Product summary11.7.4. Recent developments
11.8. Medtronic
11.8.1. Company details11.8.2. Financial outlook11.8.3. Product summary11.8.4. Recent developments
11.9. Novo Nordisk A/S
11.9.1. Company details11.9.2. Financial outlook11.9.3. Product summary11.9.4. Recent developments
11.10. Roche Diabetes Care
11.10.1. Company details11.10.2. Financial outlook11.10.3. Product summary11.10.4. Recent developments
11.11. Rossmax International Ltd.
11.11.1. Company details11.11.2. Financial outlook11.11.3. Product summary11.11.4. Recent developments
11.12. Sanofi
11.12.1. Company details11.12.2. Financial outlook11.12.3. Product summary11.12.4. Recent developments
11.13. Others
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment






Related Reports
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.